Physician profile
Christopher Bogaev
NPI 1538160106
$1,835.37
in general payments reported to CMS, 2019-2025
16 companies · $287 in 2025
The $287 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $479 · 2020: $188 · 2021: $105 · 2022: $296 · 2023: $264 · 2024: $218 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $768.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $767.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $328.17 | 2022-2025 | Percept PC Brainsense, Sensight, Intellis Adaptivestim |
| Stryker Corporation | $275.38 | 2020-2025 | Na, Universal Neuro 3 |
| Boston Scientific Corporation | $242.07 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Abbott Laboratories | $223.78 | 2019-2024 | Proclaim, Eterna |
| Ucb, INC. | $188.46 | 2019-2022 | |
| Portola Pharmaceuticals, LLC | $144.02 | 2019 | |
| Nevro Corp. | $122.68 | 2019-2023 | Senza |
| Brainlab, INC. | $60.04 | 2019 | |
| Orthofix Medical, INC. | $52.44 | 2023 | Physio-Stim, Cervical-Stim |
| Alexion Pharmaceuticals, INC. | $45.97 | 2021-2022 | |
| Medtronic USA, INC. | $33.64 | 2019-2020 | |
| Davol INC. | $32.14 | 2023 | Avitene Ultrafoam |
| Pacira Pharmaceuticals Incorporated | $25.00 | 2022 | |
| Si-Bone, INC. | $24.15 | 2024 | |
| Baxter Healthcare | $21.34 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $16.09 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Bogaev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.